Simulect

"A unique type of poster placed in exam rooms helped reduce unnecessary antibiotic prescriptions for respiratory infections during flu season. The approach could help reduce costs and extend the usefulness of these drugs.

Simulect

OVERDOSE

A maximum tolerated dose of Simulect® (basiliximab) has not been determined in patients. During the course of clinical studies, Simulect (basiliximab) has been administered to adult renal transplantation patients in single doses of up to 60 mg, or in divided doses over 3-5 days of up to 120 mg, without any associated serious adverse events. There has been one spontaneous report of a pediatric renal transplantation patient who received a single 20-mg dose (2.3 mg/kg) without adverse events.

CONTRAINDICATIONS

Simulect® (basiliximab) is contraindicated in patients with known hypersensitivity
to basiliximab or any other component of the formulation. See composition of
Simulect under DESCRIPTION.

Last reviewed on RxList: 11/7/2008
This monograph has been modified to include the generic and brand name in many instances.